Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Obesity+1

Not recruiting

Registered drug

Study on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight

Registered drug

Sweden

Participants:0–17 years
Substances:Semaglutide

Contact Research Centre

Hypersensitivity

Not recruiting

Registered drugNo placebo

Study on Dexamethasone Film for Patients with Acute Allergic Reactions

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Cardiac failure+1

Not recruiting

Investigational

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Azd3427

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Find therapies in clinical trials near you – page 26

334 trials match your criteria

Triple negative breast cancer

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Anti-glomerular basement membrane disease

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Chronic hepatitis B

Study on the Safety and Effects of RBD1016 Injection for Patients with Chronic Hepatitis B on Nucleoside Analogues Treatment

Neoplasm malignant

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Kidney transplant rejection

Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Pulmonary arterial hypertension

Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Obesity+1

Study on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight

Hypersensitivity

Study on Dexamethasone Film for Patients with Acute Allergic Reactions

Cardiac failure+1

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Bladder cancer

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Hodgkin's disease

Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Endometrial cancer

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.